NYSE Listed Company Manual

Cloopen Receives NYSE's Final Delisting Determination

Retrieved on: 
Thursday, October 26, 2023
Form 6-K, Determination, Security (finance), NYSE, Committee, OTC, NYSE Listed Company Manual, Cryptocurrency

BEIJING, Oct. 26, 2023 /PRNewswire/ -- Cloopen Group Holding Limited (OTC: RAASY) ("Cloopen" or the "Company") today announced that on October 25, 2023, it received the final delisting determination from the committee for review (the "Committee") of the board of directors of the New York Stock Exchange LLC (the "NYSE").

Key Points: 
  • BEIJING, Oct. 26, 2023 /PRNewswire/ -- Cloopen Group Holding Limited (OTC: RAASY) ("Cloopen" or the "Company") today announced that on October 25, 2023, it received the final delisting determination from the committee for review (the "Committee") of the board of directors of the New York Stock Exchange LLC (the "NYSE").
  • The Company subsequently filed with the NYSE a written request for a review of the Determination by the Committee.
  • On October 25, 2023, the Committee affirmed the Determination.
  • Prior to filing the Form 25 with the SEC, the NYSE will give public notice of its final determination to remove the Company's ADSs from listing by issuing a press release and posting a notice on its website.

China Green Agriculture, Inc. Inc. Receives NYSE Notice Regarding Late Form 10-K Filing

Retrieved on: 
Friday, October 20, 2023
Security (finance), NYSE, NYSE Listed Company Manual, Bank statement, Inc., File, Annual report, CGA, Cryptocurrency

The Company is currently working closely with its principal accounting firm to complete the filing of its 2023 Form 10-K as soon as reasonably practicable.

Key Points: 
  • The Company is currently working closely with its principal accounting firm to complete the filing of its 2023 Form 10-K as soon as reasonably practicable.
  • The NYSE has informed the Company that, under the NYSE’s rules, the Company will have six months from the filing due date to file its 2023 Form 10-K with the SEC.
  • The Company can regain compliance with the NYSE listing standards during this six-month period when the Company files its 2023 Form 10-K with the SEC.
  • During the six-month period, the NYSE will closely monitor the status of the Company’s late filing and related public disclosures.

Cazoo Announces Third Quarter 2023 Financial Results

Retrieved on: 
Wednesday, October 25, 2023
Online Retail, Retail, Automotive, Other Automotive, Other Retail, General Automotive, Specialty, Yoy, Sale, Security (finance), NYSE, Economics, Pressure, EBITDA, Quarter, Cyprus Securities and Exchange Commission, NYSE Listed Company Manual, Transaction, Cazoo, Environment, GPU, Cryptocurrency, Beauty salon, Potash

In 2023, “Other sales” comprises revenue from walk-in servicing, subscription services, third-party reconditioning and the provision of data services.

Key Points: 
  • In 2023, “Other sales” comprises revenue from walk-in servicing, subscription services, third-party reconditioning and the provision of data services.
  • For the whole of 2023 we expect to sell between 40,000-42,000 retail units and between 50,000-52,000 total units (retail and wholesale).
  • Consequently, our forecast for adjusted EBITDA remains unchanged at £(100) million to £(120) million for 2023.
  • Cazoo will host a conference call today, October 25, 2023, at 8 a.m.

NYSE to Commence Delisting Proceedings with Respect to the Warrants of Skillsoft Corp. (SKIL.WS)

Retrieved on: 
Wednesday, October 25, 2023
Professional Services, Finance, NYSE Listed Company Manual, Security (finance), NYSE, New York Stock Exchange, Committee, Bangladesh Securities and Exchange Commission, Warrant, SKIL, Exchange

The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants of Skillsoft Corp. (the “Company”), 20 exercisable for one share of Class A common stock at an exercise price of $230.00 per share (the “Warrants”) — ticker symbol SKIL.WS — from the NYSE.

Key Points: 
  • The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants of Skillsoft Corp. (the “Company”), 20 exercisable for one share of Class A common stock at an exercise price of $230.00 per share (the “Warrants”) — ticker symbol SKIL.WS — from the NYSE.
  • Trading in the Company’s Class A common stock — ticker symbol SKIL — will be unaffected and will continue on the NYSE.
  • NYSE Regulation has determined that the Company’s Warrants are no longer suitable for listing based on “abnormally low” price levels, pursuant to Section 802.01D of the Listed Company Manual.
  • The NYSE will apply to the Securities and Exchange Commission to delist the Warrants upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

D-Wave Receives Notice of Non-Compliance with NYSE Trading Share Price Listing Rule

Retrieved on: 
Tuesday, October 24, 2023
Telecommunications, Software, Networks, Internet, Hardware, Electronic Design Automation, Technology, Mobile, Wireless, NYSE, Calendar, NYSE Listed Company Manual, Cryptocurrency

The notice does not result in the immediate delisting of the Company’s common stock from the NYSE.

Key Points: 
  • The notice does not result in the immediate delisting of the Company’s common stock from the NYSE.
  • On October 24, 2023, the Company notified the NYSE that it intends to cure the stock price deficiency and to return to compliance with the NYSE continued listing standard.
  • The Company intends to consider available alternatives, including but not limited to a reverse stock split, that are subject to shareholder approval.
  • The Company’s common stock will continue to be listed and trade on the NYSE during this period, subject to the Company’s compliance with other NYSE continued listing standards.

Arcus Biosciences Announces New Employment Inducement Grants

Retrieved on: 
Tuesday, October 24, 2023
Biotechnology, Professional Services, Health, General Health, Business, Pharmaceutical, Oncology, Research, Genetics, Science, Clinical Trials, Cancer, NYSE, NYSE Listed Company Manual, Compensated emancipation, Pharmaceutical industry

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted two new employees options to purchase a total of 4,800 shares of the Company’s common stock at an exercise price per share of $16.18, which was the closing price on October 23, 2023, and restricted stock units to acquire a total of 2,400 shares of the Company’s common stock.

Key Points: 
  • Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted two new employees options to purchase a total of 4,800 shares of the Company’s common stock at an exercise price per share of $16.18, which was the closing price on October 23, 2023, and restricted stock units to acquire a total of 2,400 shares of the Company’s common stock.
  • The equity awards were granted pursuant to the Company’s 2020 Inducement Plan, which was approved by the Company’s Board of Directors in January 2020 pursuant to the “inducement exception” under NYSE Listed Company Manual Rule 303A.08.

Terran Orbital Receives NYSE Continued Listing Standards Notice

Retrieved on: 
Saturday, October 21, 2023
Defense, Technology, Satellite, Aerospace, Manufacturing, Government Technology, Orbital Corporation, NYSE, Cyprus Securities and Exchange Commission, Calendar, NYSE Listed Company Manual, Notice, LLAP

The NYSE notice does not result in the immediate delisting of the Company’s common stock from the NYSE.

Key Points: 
  • The NYSE notice does not result in the immediate delisting of the Company’s common stock from the NYSE.
  • In accordance with applicable NYSE rules, the Company plans to notify the NYSE that it intends to cure the stock price deficiency and return to compliance with the applicable NYSE continued listing standards.
  • The Company intends to remain listed on the NYSE and is considering all available options to regain compliance with the NYSE’s continued listing standards, including, but not limited to, a reverse stock split, subject to stockholder approval.
  • The NYSE notice has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and traded on the NYSE during such cure period, subject to the Company’s compliance with other NYSE continued listing standards.

Yelp Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Retrieved on: 
Thursday, October 19, 2023
Apps, Applications, Technology, Marketing, Online, Communications, Internet, Digital Marketing, Social Media, Retail, Compensated emancipation, Inc., Professional Football Compensation Committee, Yelp, NYSE, Employment, NYSE Listed Company Manual, Pharmaceutical industry

Yelp Inc. (NYSE: YELP), the company that connects people with great local businesses, announced that on October 13, 2023, the Compensation Committee of Yelp’s Board of Directors granted inducement restricted stock unit awards covering 35,542 shares of Yelp’s common stock to eight new non-executive employees to induce them to accept employment with Yelp.

Key Points: 
  • Yelp Inc. (NYSE: YELP), the company that connects people with great local businesses, announced that on October 13, 2023, the Compensation Committee of Yelp’s Board of Directors granted inducement restricted stock unit awards covering 35,542 shares of Yelp’s common stock to eight new non-executive employees to induce them to accept employment with Yelp.
  • Each award was granted under the Yelp Inc. 2023 Inducement Award Plan and vests over a four-year period, subject to continued employment with Yelp through each vesting date.
  • Each award was granted as a material inducement to employment in accordance with the NYSE Listed Company Manual Rule 303A.08.

NYSE to Commence Delisting Proceedings with Respect to the Warrants of Local Bounti Corporation (LOCL WS)

Retrieved on: 
Wednesday, October 18, 2023
Fintech, Professional Services, Finance, NYSE Listed Company Manual, Security (finance), NYSE, New York Stock Exchange, Committee, Bangladesh Securities and Exchange Commission, Warrant, Exchange

The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants of Local Bounti Corporation (the “Company”), thirteen exercisable for one share of common stock for $149.50 per share (the “Warrants”) — ticker symbol LOCL WS — from the NYSE.

Key Points: 
  • The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants of Local Bounti Corporation (the “Company”), thirteen exercisable for one share of common stock for $149.50 per share (the “Warrants”) — ticker symbol LOCL WS — from the NYSE.
  • Trading in the Company’s Warrants will be suspended immediately.
  • Trading in the Company’s common stock — ticker symbol LOCL — will continue on the NYSE.
  • NYSE Regulation has determined that the Company’s Warrants are no longer suitable for listing based on “abnormally low” price levels, pursuant to Section 802.01D of the Listed Company Manual.

NYSE to Commence Delisting Proceedings Against Rite Aid Corporation (RAD)

Retrieved on: 
Monday, October 16, 2023
Fintech, Professional Services, Finance, Bankruptcy, NYSE, Rite Aid, Bangladesh Securities and Exchange Commission, Title 11 of the United States Code, United States bankruptcy court, Committee, Exchange, NYSE Listed Company Manual, RAD, Security (finance)

The New York Stock Exchange LLC (“NYSE” or “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Rite Aid Corporation (the “Company”) — ticker symbol RAD — from the NYSE.

Key Points: 
  • The New York Stock Exchange LLC (“NYSE” or “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Rite Aid Corporation (the “Company”) — ticker symbol RAD — from the NYSE.
  • Trading in the Company’s common stock will be suspended immediately.
  • In reaching its delisting determination, NYSE Regulation noted that the restructuring term sheet contemplates that the Company’s equity holders are expected to receive no recovery.
  • The NYSE will apply to the Securities and Exchange Commission to delist the Company’s common stock upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.